These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11728539)

  • 1. Improving the image of biotechnology the European way.
    Moore A
    Lancet; 2001 Nov; 358(9294):1664. PubMed ID: 11728539
    [No Abstract]   [Full Text] [Related]  

  • 2. About audience-specific communication.
    Burlon O
    Biotechnol J; 2007 Sep; 2(9):1070-1. PubMed ID: 17722182
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic biology through the prism of scenarios.
    Rutz B
    Biotechnol J; 2007 Sep; 2(9):1072-5. PubMed ID: 17703494
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotechnology and sustainability: the role of transatlantic cooperation in research and innovation.
    Aguilar A; Bochereau L; Matthiessen-Guyader L
    Trends Biotechnol; 2008 Apr; 26(4):163-5. PubMed ID: 18295918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report: EuroBioFund first annual forum in Helsinki.
    Biotechnol J; 2007 Apr; 2(4):406-7. PubMed ID: 17407205
    [No Abstract]   [Full Text] [Related]  

  • 6. Future societal issues in industrial biotechnology.
    Schuurbiers D; Osseweijer P; Kinderlerer J
    Biotechnol J; 2007 Sep; 2(9):1112-20. PubMed ID: 17639531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The difficulty of structuring and focusing the co-existence debate in Europe.
    Custers R
    Biotechnol J; 2007 Sep; 2(9):1086-7. PubMed ID: 17703493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biotechnology consortia versus multifirm alliances: paradigm shift at work?
    Persidis A; Persidis A
    Nat Biotechnol; 1996 Dec; 14(13):1657-60. PubMed ID: 9634847
    [No Abstract]   [Full Text] [Related]  

  • 9. Scientists and societies. The Polish biotech gap.
    Gorlach S; Slabicki M
    Nature; 2004 Feb; 427(6977):870. PubMed ID: 14985771
    [No Abstract]   [Full Text] [Related]  

  • 10. Paring down the company: the effect of consolidation in the European biotech sector.
    Bassett P
    Nat Biotechnol; 2003 Jul; 21(7):829-30. PubMed ID: 12833105
    [No Abstract]   [Full Text] [Related]  

  • 11. Public perceptions of biotechnology.
    McHughen A
    Biotechnol J; 2007 Sep; 2(9):1105-11. PubMed ID: 17639530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costa Rica's biotech project still on track for end of year.
    Corrales A
    Nature; 2008 May; 453(7195):586. PubMed ID: 18509417
    [No Abstract]   [Full Text] [Related]  

  • 13. Transferring EU-funded biotechnology research to European bioindustry.
    Lawler C; van der Meer R; Viseur J
    Nat Biotechnol; 1998 Jun; 16(6):494. PubMed ID: 9624665
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydrocarbons and renewable energy.
    Ringpfeil M
    Nat Biotechnol; 2004 Sep; 22(9):1077. PubMed ID: 15340466
    [No Abstract]   [Full Text] [Related]  

  • 15. European exploitation of biotechnology-do government policies help? A recent survey of public spending on biotechnology in Europe suggests that money alone cannot stimulate growth of the sector.
    Senker J; Enzing C; Joly PB; Reiss T
    Nat Biotechnol; 2000 Jun; 18(6):605-8. PubMed ID: 10835596
    [No Abstract]   [Full Text] [Related]  

  • 16. Fears over Europe's GM crop plan.
    Chipman A
    Nature; 2010 Jul; 466(7306):542-3. PubMed ID: 20671684
    [No Abstract]   [Full Text] [Related]  

  • 17. Going it alone.
    Senior M
    Nat Biotechnol; 2014 May; 32(5):411-4. PubMed ID: 24811507
    [No Abstract]   [Full Text] [Related]  

  • 18. White biotechnology: ready to partner and invest in.
    Kircher M
    Biotechnol J; 2006; 1(7-8):787-94. PubMed ID: 16897821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The shape of European business in 2003.
    Wagner M
    Med Device Technol; 2002 Dec; 13(10):8-10. PubMed ID: 12575520
    [No Abstract]   [Full Text] [Related]  

  • 20. Possibilities for funding of applied biotechnology research in the sixth Framework Programme.
    Lucas J
    Commun Agric Appl Biol Sci; 2003; 68(2 Pt A):3-12. PubMed ID: 15296131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.